Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05772104
PHASE3

Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder

Sponsor: Sichuan Jishengtang Pharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

This is a randomized double-blind placebo-controlled phase 3 clinical trial to further validate the effectiveness and safety of Shugan Jieyu Capsules in treating generalized anxiety disorder.

Official title: A Multi-center, Randomized, Double-Blind Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

495

Start Date

2023-04-17

Completion Date

2025-06-01

Last Updated

2024-12-18

Healthy Volunteers

No

Interventions

DRUG

Shugan Jieyu Capsules

Oral, 4 Capsules, BID

DRUG

Shugan Jieyu Capsules Placebo

Drug: Shugan Jieyu Capsules Placebo, Oral,4 capsules,BID Drug: Placebo, Oral, 1 capsule, BID

Locations (1)

Beijing Anding Hospital Affiliated to Capital Medical University

Beijing, China